company background image
4127 logo

Tien Liang BioTech TPEX:4127 Stock Report

Last Price

NT$42.40

Market Cap

NT$1.9b

7D

4.7%

1Y

190.4%

Updated

23 Dec, 2024

Data

Company Financials

Tien Liang BioTech Co., Ltd.

TPEX:4127 Stock Report

Market Cap: NT$1.9b

4127 Stock Overview

Manufactures and sells pharmaceutical products in Taiwan and internationally. More details

4127 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends1/6

Risk Analysis

Does not have a meaningful market cap (NT$2B)

Profit margins (3.5%) are lower than last year (5.4%)


My Notes

Capture your thoughts, links and company narrative

Tien Liang BioTech Co., Ltd. Competitors

Chunghwa Chemical Synthesis & Biotech

TWSE:1762

NT$2.6b

Chi Sheng Pharma & Biotech

TPEX:4111

NT$1.6b

Winston Medical Supply

TPEX:6817

NT$1.7b

Genovate Biotechnology

TPEX:4130

NT$2.3b

Price History & Performance

Summary of share price highs, lows and changes for Tien Liang BioTech
Historical stock prices
Current Share PriceNT$42.40
52 Week HighNT$47.80
52 Week LowNT$13.90
Beta0.56
1 Month Change16.80%
3 Month Change21.66%
1 Year Change190.41%
3 Year Change187.46%
5 Year Change354.45%
Change since IPO89.55%

Recent News & Updates

Recent updates

Is Tien Liang BioTech (GTSM:4127) Using Too Much Debt?

Apr 19
Is Tien Liang BioTech (GTSM:4127) Using Too Much Debt?

Tien Liang BioTech (GTSM:4127) Is Carrying A Fair Bit Of Debt

Jan 04
Tien Liang BioTech (GTSM:4127) Is Carrying A Fair Bit Of Debt

Shareholder Returns

4127TW PharmaceuticalsTW Market
7D4.7%-0.01%-2.1%
1Y190.4%-2.7%25.6%

Return vs Industry: 4127 exceeded the TW Pharmaceuticals industry which returned -2.7% over the past year.

Return vs Market: 4127 exceeded the TW Market which returned 25.6% over the past year.

Price Volatility

Is 4127's price volatile compared to industry and market?
4127 volatility
4127 Average Weekly Movement4.8%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4127 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4127's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196060Min-Chung Chiwww.tlb.com.tw

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete’s foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, hair removal cream, tablet, capsule, soreness spray, and pain patch products, as well as pain relief gels.

Tien Liang BioTech Co., Ltd. Fundamentals Summary

How do Tien Liang BioTech's earnings and revenue compare to its market cap?
4127 fundamental statistics
Market capNT$1.94b
Earnings (TTM)NT$14.56m
Revenue (TTM)NT$414.94m

133.3x

P/E Ratio

4.7x

P/S Ratio

Is 4127 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4127 income statement (TTM)
RevenueNT$414.94m
Cost of RevenueNT$157.45m
Gross ProfitNT$257.48m
Other ExpensesNT$242.93m
EarningsNT$14.56m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.32
Gross Margin62.05%
Net Profit Margin3.51%
Debt/Equity Ratio54.6%

How did 4127 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

157%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:09
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tien Liang BioTech Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Li-chun ChangJih Sun Securities Investment Consulting Co., Ltd.